This type of experimental sequencing verification illustrates the reliability of the network pharmacology analysis but also indicates that we need to combine differences of different tumors and heterogeneity of the same tumor to study the anti-cancer effects and mechanism of action of CKI. The gene discussed is CHKA; the disease is neoplasm.